Photoresponsive Nitric Oxide Release from Aggregation-Induced Emission-Based Ruthenium-Nitrosyl Complexes and Their Anticancer Activity through In Situ Formation of Peroxynitrite

Nitric oxide (NO) is recognized as a gaseous chemical mediator that regulates various physiological functions. Two naphthalene-appended terpyridine-based mononuclear ruthenium-nitrosyl complexes with the molecular framework [1.Ru2+(L)NO](PF6)3 (L = 2,2'-bipyridine (bpy) or phenanthroline (phen) and 1 = 4'-(anthracene-9-yl)-2,2':6',2″-terpyridine), named 1.Ru(bpy)NO and 1.Ru(phen)NO, were reported for NO delivery. The introduction of ancillary ligands (bpy and phen) to the Ru-center led to the noticeable variations of photophysical properties and aggregation behavior in aqueous solution, which helps to modulate the NO release. Both the complexes facilitate the photocleavage of the Ru-NO bond on exposure to either blue (410 nm) or green light (525 nm) in CH3CN and CH3CN-H2O (20/80, v/v) mixture. The photo release kinetics of 1.Ru(bpy)NO and 1.Ru(phen)NO have been studied in detail and confirmed by IR studies, the Griess assay, and the DAF assay. The interaction of photoinduced NO and singlet oxygen (1O2) and thereby formation of peroxynitrite (ONOO-) were confirmed by the emission assay. The cytotoxicity MTT assay of these complexes with human neuroblastoma cancerous cells with or without green light irradiation was also investigated. Notably, the in situ formation of ONOO- on cells produces potent anticancer effects that originated from NO and 1O2 in an aqueous solution.

Synthesis, structure, spectra, cytotoxicity and photo induced NO release of four isomeric nitrosylruthenium complexes

Four isomeric nitrosyl ruthenium complexes [RuCl(2mqn)(Val)(NO)] (1-4) were prepared (2mqn, 2-methyl-8-hydroxyquinoline; Val, l-valine) and characterized by 1H NMR, 13C NMR, absorption spectrum, electrospray ionization mass spectrometry, and X-ray crystal diffraction. Time-resolved FT-IR and fluorescence spectroscopy were used to monitor photo-induced NO release in solution, while NO released in living cells was imaged using a selective fluorescent probe. The isomeric complexes showed different levels of cytotoxicity against HeLa cells, and slightly photo-enhanced anti-proliferative activity was observed. The isomeric complexes 1-4 inhibited the growth of HeLa cells by inducing apoptosis and promoted cell cycle arrest in the S phase. Furthermore, they showed relatively lower cytotoxicity against the human liver cell line HL-7702. The different spatial configurations of the complexes is close related with the selective binding of the isomeric complexes with serum albumin, which provide insight into the potential applications of the nitrosyl ruthenium complexes.

Unravelling the kinetics of electro- and photochemical S → O linkage isomerization in Ru(II)-NHC-DMSO complexes utilised for photoinduced substitution reactions

Our recently reported Ru(III)-NHC complexes 1a and 1b were utilized as suitable precursors to prepare new Ru(II)-NHC-(DMSO)2 complexes 2a and 2b. Complexes 2a and 2b reacted with 2,2'-bipyridine to give complexes 3a and 3b, respectively, with substitution of only one of the DMSO ligands. All new complexes were characterized using various spectroscopic techniques and the molecular structures of 2a and 3a were determined using single-crystal X-ray diffraction technique. Complexes 2a, 2b, 3a, and 3b showed the S → O linkage isomerization of the DMSO ligand upon oxidation of the Ru centre from +II to +III, as confirmed by the thermodynamic and kinetic data obtained from cyclic voltammetry experiments. It was observed that in the bisdimethylsulfoxide complexes 2a and 2b, only one DMSO ligand isomerized, which was further corroborated by the computational studies performed to optimize the geometry of the possible linkage isomers of complexes 2a and 3a in +2 and +3 oxidation states, whereas complexes 3a and 3b showed a high preference for the O-bound isomer in the Ru(III) redox state. The role of NHC in stabilizing the mixed isomer in complexes 2a and 2b and preventing the isomerization of both DMSO ligands coordinated to the Ru centre was studied; moreover, NHC provided good solvent compatibility for photochemical S → O isomerization in all the complexes. Taking advantages of the photoinduced linkage isomerization in 2a and 2b, the synthesis of 3a and 3b was revisited and performed using 2a and 2b, respectively, following a photoinduced substitution reaction in the presence of 2,2'-bipyridine. The kinetics of the reversion from the O-bound to S-bound isomer was found to follow the DMSO-assisted intermolecular S → O isomerization pathway.

Insight into the anti-proliferation activity and photoinduced NO release of four nitrosylruthenium isomeric complexes and their HSA complex adducts

Four Ru(II)-centered isomeric complexes [RuCl(5cqn)(Val)(NO)] (1-4) were synthesized with 5cqn (5-chloro-8-hydroxyquinoline) and chiral Val (Val = L- or D-valine) as co-ligand, and their structures were confirmed using the X-ray diffraction method. The cytotoxicity and photodynamic activity of the isomeric complexes and their human serum albumin (HSA) complex adducts were evaluated. Both the isomeric complexes and their HSA complex adducts significantly affected HeLa cell proliferation, with an IC50 value in the range of 0.3-0.5 μM. The photo-controlled release of nitric oxide (NO) in solution was confirmed using time-resolved Fourier transform infrared and electron paramagnetic resonance spectroscopy techniques. Furthermore, photoinduced NO release in living cells was observed using a selective fluorescent probe for NO. Moreover, the binding constants (Kb) of the complexes with HSA were calculated to be 0.17-1.98 × 104 M-1 and the average number of binding sites (n) was found to be close to 1, it can serve as a crucial carrier for delivering metal complexes. The crystal structure of the HSA complex adduct revealed that one [RuCl(H2O)(NO)(Val)]+ molecule binds to a pocket in domain I. This study provides insight into possible mechanism of metabolism and potential applications for nitrosylruthenium complexes.

A Trojan horse approach for enhancing the cellular uptake of a ruthenium nitrosyl complex

Ruthenium nitrosyl (RuNO) complexes continue to attract significant research interest due to several appealing features that make these photoactivatable nitric oxide (NO˙) donors attractive for applications in photoactivated chemotherapy. Interesting examples of molecular candidates capable of delivering cytotoxic concentrations of NO˙ in aqueous media have been discussed. Nevertheless, the question of whether most of these highly polar and relatively large molecules are efficiently incorporated by cells remains largely unanswered. In this paper, we present the synthesis and the chemical, photophysical and photochemical characterization of RuNO complexes functionalized with 17α-ethinylestradiol (EE), a semisynthetic steroidal hormone intended to act as a molecular Trojan horse for the targeted delivery of RuNO complexes. The discussion is centered around two main molecular targets, one containing EE (EE-Phtpy-RuNO) and a reference compound lacking this biological recognition fragment (Phtpy-RuNO). While both complexes displayed similar optical absorption profiles and NO˙ release efficiencies in aqueous media, important differences were found regarding their cellular uptake towards dermal fibroblasts, with EE-Phtpy-RuNO gratifyingly displaying a remarkable 10-fold increase in cellular uptake when compared to Phtpy-RuNO, thus demonstrating the potential drug-targeting capabilities of this biomimetic steroidal conjugate.

Ru(II) based dual nitric oxide donors: electrochemical and photochemical reactivities and vasorelaxant effect with no cytotoxicity

The synthesized complexes, cis-[Ru(NO)(NO2)(phen)2](PF6)2 (NONO2P) and cis-[Ru(NO)(NO2)(bpy)2](PF6)2 (NONO2B), were characterized by using elemental analysis, voltammetry and electronic and vibrational spectroscopy. Under electrochemical and photochemical stimulation in an aqueous medium, there are indications of the formation of complexes, which suggests that the nitro and nitrosyl groups are converted into nitric oxide. Both compounds do not show cytotoxic activity against human umbilical vein endothelial cells (HUVECs). The cis-[Ru(NO)(NO2)(phen)2](PF6)2 complex presented vasorelaxation activity in superior mesenteric arteries from Wistar rats: the biphasic concentration-response curve indicates two sites of action. In the presence of NO scavengers, we observed an impaired relaxing effect induced by NONO2P, suggesting that the vasorelaxant effect is due to NO production from this compound.

Recent Advances in Photorelease Complexes for Therapeutic Applications”

Photorelease complexes represent a class of agents for which UV-visible light triggers the expulsion of a specfic molecule that is intrinsically part of the inner coordination sphere or held in...

Ruthenium-nitrosyl complexes as NO-releasing molecules and potential anticancer drugs

The synthesis of new types of mono- and polynuclear ruthenium nitrosyl complexes is driving progress in the field of NO generation for a variety of applications. Light-induced Ru-NO bond dissociation...

High phenoxazinone synthase activity of two mononuclear cis-dichloro cobalt(ii) complexes with a rigid pyridyl scaffold

Two mononuclear cis-dichloro cobalt(II) complexes with bidentate pyridyl ligands have been successfully synthesized and employed as active o-aminophenol oxidation catalysts resulting in high turnover numbers under aerobic conditions.